BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15456860)

  • 1. Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells.
    Paredes R; Arriagada G; Cruzat F; Villagra A; Olate J; Zaidi K; van Wijnen A; Lian JB; Stein GS; Stein JL; Montecino M
    Mol Cell Biol; 2004 Oct; 24(20):8847-61. PubMed ID: 15456860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity.
    Sierra J; Villagra A; Paredes R; Cruzat F; Gutierrez S; Javed A; Arriagada G; Olate J; Imschenetzky M; Van Wijnen AJ; Lian JB; Stein GS; Stein JL; Montecino M
    Mol Cell Biol; 2003 May; 23(9):3339-51. PubMed ID: 12697832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Runx2 transcription factor plays a key role in the 1alpha,25-dihydroxy Vitamin D3-dependent upregulation of the rat osteocalcin (OC) gene expression in osteoblastic cells.
    Paredes R; Arriagada G; Cruzat F; Olate J; Van Wijnen A; Lian J; Stein G; Stein J; Montecino M
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):269-71. PubMed ID: 15225783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the 1alpha,25-dihydroxyvitamin D3 receptor at the distal promoter region of the bone-specific osteocalcin gene requires nucleosomal remodelling.
    Paredes R; Gutiérrez J; Gutierrez S; Allison L; Puchi M; Imschenetzky M; van Wijnen A; Lian J; Stein G; Stein J; Montecino M
    Biochem J; 2002 May; 363(Pt 3):667-76. PubMed ID: 11964167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha,25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1alpha,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex.
    Carvallo L; Henríquez B; Paredes R; Olate J; Onate S; van Wijnen AJ; Lian JB; Stein GS; Stein JL; Montecino M
    J Cell Physiol; 2008 Mar; 214(3):740-9. PubMed ID: 17786964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vitamin D response element in the distal osteocalcin promoter contributes to chromatin organization of the proximal regulatory domain.
    Gutierrez S; Liu J; Javed A; Montecino M; Stein GS; Lian JB; Stein JL
    J Biol Chem; 2004 Oct; 279(42):43581-8. PubMed ID: 15299011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
    Lu X; Farmer P; Rubin J; Nanes MS
    J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
    Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
    Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression.
    Xiao G; Jiang D; Ge C; Zhao Z; Lai Y; Boules H; Phimphilai M; Yang X; Karsenty G; Franceschi RT
    J Biol Chem; 2005 Sep; 280(35):30689-96. PubMed ID: 16000305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 1alpha,25-dihydroxy Vitamin D3 receptor preferentially recruits the coactivator SRC-1 during up-regulation of the osteocalcin gene.
    Carvallo L; Henriquez B; Olate J; van Wijnen AJ; Lian JB; Stein GS; Onate S; Stein JL; Montecino M
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):420-4. PubMed ID: 17218095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter.
    Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ
    Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene.
    Guo B; Aslam F; van Wijnen AJ; Roberts SG; Frenkel B; Green MR; DeLuca H; Lian JB; Stein GS; Stein JL
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):121-6. PubMed ID: 8990171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
    van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
    J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression.
    Gutierrez S; Javed A; Tennant DK; van Rees M; Montecino M; Stein GS; Stein JL; Lian JB
    J Biol Chem; 2002 Jan; 277(2):1316-23. PubMed ID: 11668178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AP-1 and vitamin D receptor (VDR) signaling pathways converge at the rat osteocalcin VDR element: requirement for the internal activating protein-1 site for vitamin D-mediated trans-activation.
    Aslam F; McCabe L; Frenkel B; van Wijnen AJ; Stein GS; Lian JB; Stein JL
    Endocrinology; 1999 Jan; 140(1):63-70. PubMed ID: 9886808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors.
    Liu M; Freedman LP
    Mol Endocrinol; 1994 Dec; 8(12):1593-604. PubMed ID: 7708050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of the interaction between Runx2 and VDR, two transcription factors involved in osteoblastogenesis.
    Marcellini S; Bruna C; Henríquez JP; Albistur M; Reyes AE; Barriga EH; Henríquez B; Montecino M
    BMC Evol Biol; 2010 Mar; 10():78. PubMed ID: 20236534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of 1,25-dihydroxyvitamin D3 receptor-mediated enhancement of osteocalcin gene transcription: effects of perturbing phosphorylation pathways by okadaic acid and staurosporine.
    Desai RK; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Endocrinology; 1995 Dec; 136(12):5685-93. PubMed ID: 7588324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.